• WedgeBayer Pharmaceuticals (Rx) is a SEPARATE scope from Consumer Health — IPG win covers only Consumer Health. WPP can still pitch Rx TW (Eylea retinal, Xarelto anticoagulant, Nubeqa oncology)
• WhyUser brief said 'Bayer WPP/Mindshare since 2014' — that is OUTDATED. WPP's EssenceMediacom (formerly MediaCom) had 65-market Bayer Consumer Health relationship through ~2024.
• Who ·

1. W1Bayer Pharmaceuticals (Rx) is a SEPARATE scope from Consumer Health — IPG win covers only Consumer Health. WPP can still pitch Rx TW (Eylea retinal, Xarelto anticoagulant, Nubeqa oncology)
2. W2Eylea (aflibercept) anti-VEGF retinal is a major TW HCP scope — ophthalmology marketing has specialized agency needs
3. W3Nubeqa (darolutamide) prostate cancer launch — fresh TW oncology surface
4. W4TW-local Bepanthen mother-baby cultural marketing — may have local agency latitude beneath global IPG
5. W5Pharmacy shopper marketing (Watsons/Cosmed) — local execution wedge
6. W6AI / Interact narrative: Bayer chose IPG partly on AI capabilities — WPP Open / Venture AI Agency can counter-pitch with stronger AI positioning
7. W7Acknowledge IPG incumbency on Consumer Health honestly — pivot to Pharmaceuticals + TW-local execution

• User brief said 'Bayer WPP/Mindshare since 2014' — that is OUTDATED. WPP's EssenceMediacom (formerly MediaCom) had 65-market Bayer Consumer Health relationship through ~2024.
• Oct 2025 — Bayer Consumer Health consolidated ALL global creative + production + media with IPG (Interpublic). This is a $720M global account WPP LOST to IPG.
• Pre-Oct 2025: WPP's EssenceMediacom on Aspirin campaign, IPG's MullenLowe on Rennie, Omnicom's BBDO on Claritin — multi-shop fragmentation that Bayer consolidated.
• The IPG win covers Aspirin, Claritin, Alka-Seltzer, Bepanthen, Berocca, Aleve, One A Day, Redoxon, Iberogast — the full Consumer Health portfolio.
• Bayer Pharmaceuticals (Eylea, Xarelto, Nubeqa) is a SEPARATE scope from Consumer Health — different agency relationships likely, Rx-side has not been publicly consolidated to IPG.
• AI emphasis: IPG won partly on AI capability — Bayer using IPG's Interact AI suite for self-care marketing efficiency.

• Bayer Taiwan Country Lead (name not publicly confirmed)Country Division Head, Bayer Taiwan

  since unknown

  Bayer Taiwan operates 3 divisions: Pharmaceuticals (Eylea, Xarelto, Nubeqa, women's health), Consumer Health (Aspirin, Bepanthen, Berocca, Aleve, One A Day, Redoxon, Iberogast), and Crop Science. Consumer Health is the meaningful brand-marketing scope in TW. Reports into APAC.

  Source ↗

Three-division MNC: Pharmaceuticals (Rx — Eylea, Xarelto, Nubeqa), Consumer Health (OTC + wellness — Aspirin, Bepanthen, Berocca, Aleve, One A Day, Redoxon, Iberogast), Crop Science (B2B agro). Consumer Health is the meaningful TW brand-marketing surface. As of Oct 2025, Bayer Consumer Health consolidated globally with IPG — WPP LOST this $720M account. AI-led integrated model (IPG Interact).

• Aspirin Heart Risk Assessment digital tool2024 · EssenceMediacom (WPP — legacy, until 2025 IPG transition) · Digital tool + content

  Bayer Aspirin Heart Risk Assessment online tool — consumer cardiovascular education. Heart-health positioning for Aspirin Cardio (low-dose).

  Source ↗
• Aspirin Super Bowl Gen X/Millennial heart-health2024 · EssenceMediacom (WPP — legacy) · Mass-market TVC

  Super Bowl spot waking Gen X + Millennials to heart-disease risk; global brand platform with TW adaptation.

  Source ↗
• Bepanthen skincare for babies & wound care2024 · IPG MullenLowe (legacy) / IPG global (post-Oct 2025) · TVC + retail

  Bepanthen baby skincare + adult wound-healing. Mother-targeted in TW; Watsons/Cosmed pharmacy distribution.

  Source ↗
• Berocca multivitamin energy2024 · Multi-shop legacy → IPG (post-Oct 2025) · Digital + retail

  Effervescent multivitamin energy positioning; office-worker target in TW.

  Source ↗

Don't pitch Aspirin/Bepanthen/Berocca/Aleve/One A Day on Consumer Health — IPG just won this Oct 2025 globally. Don't ignore the AI angle — IPG won partly on Interact AI; counter-pitch with WPP Open / AI capabilities. Pivot to Pharmaceuticals (Eylea, Xarelto, Nubeqa) and TW-local pharmacy shopper marketing where IPG global may not have depth.

• Haleon Taiwan (Voltaren vs Aspirin/Aleve, Centrum vs Berocca/One A Day, Panadol vs Aspirin)
• Kenvue Taiwan (Tylenol — direct pain competitor)
• Reckitt Taiwan (Nurofen, Strepsils)
• Sanofi (Allegra vs Bayer allergy)
• Local TW OTC: Yungshin, TTY

• ? Who holds Bayer Pharmaceuticals (Rx) media globally — still WPP/Mindshare or shifted?
• ? TW-local agency executing tactical work beneath IPG global Consumer Health?
• ? Bayer Taiwan country leadership names
• ? Eylea TW HCP marketing — separate agency or part of broader Rx scope?